Imugene (IMU) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Imugene Limited Updates and Focus on Cancer TherapiesNovember 21, 2024 | markets.businessinsider.comImugene Limited Announces Director Change and Stock HoldingsNovember 21, 2024 | markets.businessinsider.comImugene Limited: Leading Innovation in Cancer TreatmentNovember 14, 2024 | markets.businessinsider.comImugene Limited Advances Amidst AGM Vote ChallengesNovember 14, 2024 | markets.businessinsider.comASX Market Update: Index retreats as Chinese stimulus disappoints | November 11, 2024November 11, 2024 | msn.comImugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analystsNovember 11, 2024 | au.investing.comImugene Limited Begins Innovative Cancer TrialNovember 11, 2024 | markets.businessinsider.comImugene Launches Phase 1b Trial in AustraliaNovember 8, 2024 | markets.businessinsider.comImugene kicks off Australian trial for blood cancer treatmentNovember 8, 2024 | msn.comROS1 Inhibitors Market Booms as Demand for Targeted Cancer Therapies Escalates | DelveInsightNovember 6, 2024 | finance.yahoo.comImugene Achieves Milestone in Cancer Treatment TrialNovember 5, 2024 | markets.businessinsider.comWhy Core Lithium, Imugene, Lifestyle Communities, and Mineral Resources shares are charging higherNovember 5, 2024 | msn.comThe Woolworths share price just hit a 52-week low: Is it a buy?November 3, 2024 | msn.com2 All Ords ASX healthcare shares making BIG moves on quarterly updatesOctober 31, 2024 | msn.comAdvanced Gastric Carcinoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersOctober 25, 2024 | theglobeandmail.comChartWatch ASX Scans: CAR Group, Clarity Pharmaceuticals, EBOS Group, Nick Scali, Nuix, Regis Resources, Sonic HealthcareSeptember 22, 2024 | msn.comAussie shares unchanged with all eyes on US rates callSeptember 18, 2024 | msn.comImugene Ltd Azer-cel Trial Update TranscriptSeptember 14, 2024 | gurufocus.comPrecision BioSciences Receives $13 Million in Proceeds from Imugene Convertible Note Maturity as Part of the August 2023 Azer-cel DealSeptember 3, 2024 | tmcnet.comThree Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)September 3, 2024 | finance.yahoo.comAust shares dip as REA Group mulls big takeover offerSeptember 3, 2024 | msn.comAustralian Market Modestly LowerSeptember 2, 2024 | markets.businessinsider.comStellar Resources confirms robust Heemskirk Tin Project with updated scoping studySeptember 2, 2024 | proactiveinvestors.comWhy this ASX All Ords stock is soaring 30% on MondaySeptember 2, 2024 | fool.com.auWhy Appen, Cettire, DroneShield, and Imugene shares are racing higherSeptember 2, 2024 | msn.comASX Health Stocks: Imugene reveals promise in lymphoma trial, stock soars 27pcSeptember 2, 2024 | msn.comALK Inhibitors Market: A Comprehensive Overview of Current Trends and Future Projections | DelveInsightAugust 30, 2024 | finance.yahoo.comImugene Ltd (IMU)August 30, 2024 | investing.comDelveInsight Business Research, LLP: Global Chemotherapy Drugs Market to Grow Substantially at a CAGR of ~9% by 2030 | DelveInsightAugust 22, 2024 | finanznachrichten.deBreakeven On The Horizon For Imugene Limited (ASX:IMU)August 8, 2024 | finance.yahoo.comImugene Limited (ILA.F)August 3, 2024 | finance.yahoo.comResection for Early Liver Cancer Tied to Improved SurvivalMay 16, 2024 | msn.comFrom high-tech cancer fighters to AI-wielding crime busters, these are some of the most innovative firms on the ASXMay 13, 2024 | msn.com‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialledApril 26, 2024 | theguardian.comThose who invested in Imugene (ASX:IMU) five years ago are up 361%April 25, 2024 | finance.yahoo.comBroker says this ASX biotech stock could almost double in valueApril 23, 2024 | msn.comCell therapy firm acquires RTP manufacturing facilityApril 17, 2024 | bizjournals.comImugene partners with Kincell Bio; selling cell therapy manufacturing facility for $6 millionApril 16, 2024 | finance.yahoo.comBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohortApril 15, 2024 | markets.businessinsider.comBile Tract Cancer expansion study opens following clearance of Imugene’s MAST trial high dose cohortApril 15, 2024 | finance.yahoo.comImugene opens enrolment for Bile Tract Cancer expansion studyApril 15, 2024 | finance.yahoo.comASX Health Stocks: Atomo sells more HIV Self-Tests; Actinogen begins Phase 2b trial on Alzheimer’sApril 15, 2024 | msn.comCity of Hope Scientists Present Leading-Edge Research at American Association for Cancer Research (AACR) Annual MeetingApril 10, 2024 | finance.yahoo.comImugene Limited: Imugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024April 9, 2024 | finanznachrichten.deImugene's oncolytic virotherapy VAXINIA and B cell immunotherapy HER-Vaxx featured at the AACR Annual Meeting 2024April 9, 2024 | finance.yahoo.comGuess which ASX 300 healthcare stock is storming higher on Chinese patent newsApril 3, 2024 | msn.comPrecision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business UpdateMarch 27, 2024 | finance.yahoo.comU.S. Food and Drug Administration (FDA) Has Accepted the New Drug Application (NDA) for EnsartinibMarch 15, 2024 | finance.yahoo.comPendulum Therapeutics Introduces GLP-1 ProbioticMarch 14, 2024 | finance.yahoo.comUnityPoint in Des Moines releases renderings for mental health expansionMarch 13, 2024 | finance.yahoo.com Get Imugene News Delivered to You Automatically Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. IMU Media Mentions By Week IMU Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMU News Sentiment▼-0.970.51▲Average Medical News Sentiment IMU News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMU Articles This Week▼21▲IMU Articles Average Week Get Imugene News Delivered to You Automatically Sign up to receive the latest news and ratings for IMU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News Alvotech News American Premium Mining News Anew Medical News Arno Therapeutics News AstraZeneca News AVVAA World Health Care Products News Basilea Pharmaceutica News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IMU) was last updated on 11/25/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imugene Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Imugene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
